Mutational Analysis Reinforces the Diagnosis of Nodal Marginal Zone Lymphoma With Robust PD1-positive T-Cell Hyperplasia

Affiliations

¹ Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania Philadelphia, PA.
² Department of Pathology, University of Michigan, Ann Arbor, MI.

Comment

Stephanie N Hurwitz et al. Am J Surg Pathol. 2021 Jan.

. 2021 Jan;45(1):143-145.

doi: 10.1097/PAS.0000000000001515.

¹ Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania Philadelphia, PA.
² Department of Pathology, University of Michigan, Ann Arbor, MI.

No abstract available

Comment on

Expansion of PD1-positive T Cells in Nodal Marginal Zone Lymphoma: A Potential Diagnostic Pitfall.
Egan C, Laurent C, Alejo JC, Pileri S, Campo E, Swerdlow SH, Piris M, Chan WC, Warnke R, Gascoyne RD, Xi L, Raffeld M, Pittaluga S, Jaffe ES. Egan C, et al. Am J Surg Pathol. 2020 May;44(5):657-664. doi: 10.1097/PAS.0000000000001414. Am J Surg Pathol. 2020. PMID: 31764221 Free PMC article.

1. Egan C, Laurent C, Alejo JC, et al. Expansion of PD1-positive T cells in nodal marginal zone lymphoma: a potential diagnostic pitfall. Am J Surg Pathol. 2020;44:657–664.
1. Pillonel V, Juskevicius D, Ng CKY, et al. High-throughput sequencing of nodal marginal zone lymphomas identifies recurrent BRAF mutations. Leukemia. 2018;32:2412–2426.
1. Parry M, Rose-Zerilli MJ, Ljungström V, et al. Genetics and prognostication in splenic marginal zone lymphoma: revelations from deep sequencing. Clin Cancer Res. 2015;21:4174–4183.
1. Kiel MJ, Velusamy T, Betz BL, et al. Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma. J Exp Med. 2012;209:1553–1565.
1. Rossi D, Trifonov V, Fangazio M, et al. The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development. J Exp Med. 2012;209:1537–1551.